{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 53: Frank David, Founder and Managing Director, Pharmagellan","slug":"episode-53-frank-david-founder-and-managing-director-pharmagellan","published_at":"2025-04-29T10:35:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-53-frank-david-founder-and-managing-director-pharmagellan","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-53-frank-david-founder-and-managing-director-pharmagellan","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2021898/c1e-x878rs9d9mzi0pvxx-okmpk0m9f5rp-3afyvc.mp3","summary":"How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan to the podcast. Tune in as we explore R&D strategy, de-risking tactics, and how to think about valuation. Listen in to the latest episode of the Biorasi Few & Far Between podcast today!","meta_description":"How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharma…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3046,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-53-frank-david-founder-and-managing-director-pharmagellan/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-53-frank-david-founder-and-managing-director-pharmagellan.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}